CPT code 30130 represents excision of the inferior turbinate, a surgical intervention commonly used to treat turbinate hypertrophy that produces significant nasal airway obstruction. As a targeted otolaryngology procedure, it addresses functional impairment and can affect downstream utilization of medical therapy and ancillary services. Nationally, this code matters because it intersects surgical practice patterns, outpatient surgical capacity, and payer policies for coverage of procedural versus conservative management.

Key payers discussed include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find a concise overview of clinical intent and sites of service, typical payer coverage considerations, and common modifiers used with the code. The publication also summarizes expected benchmarks for service settings and utilization drivers, highlights relevant coding context for billing operations, and outlines where to look for policy updates that affect prior authorization and reimbursement pathways.

This summary is intended to give clinicians, billing professionals, and policy analysts a clear, national-level understanding of what CPT code 30130 represents, why it is clinically and operationally significant, and what to consider when preparing claims and monitoring payer policies.